Current Approaches to Cryo-electron Microscopy
- 1st Edition, Volume 223 - September 1, 2026
- Latest edition
- Editor: David B. Teplow
- Language: English
Cryo-electron microscopy (cryo-EM) has emerged as a transformative technique in structural biology, driving an exponential increase in the number of structures deposited in the… Read more
Robotics & automation week
Empowering Progress
Up to 20% on Robotics and Automation Resources!
Jaekyung Hyun and Seu-Na Lee
2. TBD
Salvador Ventura
3. Pursuing the physics of cryoEM image formation
Duane Loh and Joel Yeo
4. AI Tools for Cryo-EM: Protein Particle Picking, Density Map Enhancement, and Atomic Model Building
Janlin Cheng, Ashwin Dhakal, Rajan Gyawali and Joel Selvaraj
5. Cryo-EM of Amyloid Fibrils: Advances, Challenges, and Translational Applications
Michal Maj and Dylan Valli
6. TBD
Alex de Marco
7. Computational Approaches for Protein Complex Modeling for Intermediate Resolution Cryo-EM Maps
Kihara Daisuke
8. Calcium-sensing receptor, involved in the oral perception of the kokumi substances
Hiroki Yamaguchi and Seiji Kitajima
9. Insights into the Structure and Diversity of the Bacterial Flagellum from cryo-EM studies
Julien Bergeron, Matias R. Iglesias Rando and Kailin Qin
10. TBD
Toshio Moriya
11. TBD
Brent Nannenga
12. Overview and future potential in structural studies of bacteriophages by cryo-electron microscopy
Michael Sherman and Elena Orlova
13. TBA
Seth Darst
- Edition: 1
- Latest edition
- Volume: 223
- Published: September 1, 2026
- Language: English
DT
David B. Teplow
David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.